Core Alternative Capital’s Labcorp LH Stock Holding History

Core Alternative Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$574	–	291
2025 Q3	$574	Hold	2	–	–	﹤0.01%	313
2025 Q2	$525	Hold	2	–	–	﹤0.01%	313
2025 Q1	$465	Hold	2	–	–	﹤0.01%	314
2024 Q4	$459	Hold	2	–	–	﹤0.01%	334
2024 Q3	$447	Hold	2	–	–	﹤0.01%	339
2024 Q2	$407	Hold	2	–	–	﹤0.01%	341
2024 Q1	$437	Sell	2 -31	-94%	-$6.83K	﹤0.01%	335
2023 Q4	$7.52K	Sell	33 -2	-6%	-$420	﹤0.01%	331
2023 Q3	$7.05K	Sell	35 -6	-15%	-$1.27K	﹤0.01%	353
2023 Q2	$8.46K	Buy	41 +5	+14%	+$970	﹤0.01%	329
2023 Q1	$7.12K	Buy	36 +2	+6%	+$412	﹤0.01%	341
2022 Q4	$6.84K	Sell	34 -43	-56%	-$8.4K	﹤0.01%	332
2022 Q3	$14K	Hold	77	–	–	﹤0.01%	249
2022 Q2	$15K	Buy	77 +7	+10%	+$1.49K	﹤0.01%	241
2022 Q1	$16K	Buy	70 +63	+900%	+$14.8K	﹤0.01%	228
2021 Q4	$2K	Buy	+7	New	+$1.73K	﹤0.01%	312

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Core Alternative Capital's LH Position: Q4 2025 in Review

Core Alternative Capital sold out of Labcorp (LH) in Q4 2025, closing a stake of 2 shares — an estimated $574 sold.

Core Alternative Capital first reported a position in LH in Q4 2021 and held it in 16 quarters. The position peaked at $16K in Q1 2022. 1,029 funds tracked by Wall St. Rank hold LH as of Q4 2025.

Core Alternative Capital reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
Core Alternative Capital sold 2 Labcorp shares in Q4 2025, an estimated $574.
Core Alternative Capital first reported a position in Labcorp in Q4 2021 and held it in 16 quarters.
Core Alternative Capital's Labcorp position peaked at $16K in Q1 2022.
1,029 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Core Alternative Capital's 13F filing for Q4 2025, filed 2 Feb 2026.